小药盒，大政策：慢性病证明与医保改革的民生共鸣

Core Insights - The article discusses the impact of healthcare policy reforms on chronic disease patients in China, highlighting the balance between personal account reductions and increased social insurance coverage [1][4][6] Group 1: Policy Changes and Their Effects - The healthcare policy in Jilin Province has undergone three adjustments from 2023 to 2025, significantly reducing out-of-pocket expenses for chronic disease medications [1][4] - The monthly contributions to personal accounts for retirees have decreased from 240 yuan in 2022 to 111 yuan in 2023, and further to 78 yuan in 2024, reflecting a shift towards increased reimbursement rates [2][3] - New outpatient reimbursement policies have been introduced, increasing reimbursement rates by 5% and lowering the threshold for chronic disease patients, thus enhancing financial support for those with chronic conditions [3][4] Group 2: Financial Implications for Patients - Patients like Zhang Guilan and Li Hongmei have reported reduced personal expenses due to the new reimbursement policies, despite lower personal account contributions [3][5] - The introduction of a "public servant medical subsidy" in 2025 aims to provide additional support for retired civil servants, reflecting a targeted approach to healthcare funding [4][6] - The overall trend indicates a move from individual account reliance to a more collective insurance model, enhancing the mutual support capacity of the healthcare system [4][6] Group 3: Broader Implications for Healthcare Access - The reforms aim to address the inequities in healthcare access between urban and rural areas, with improvements in the availability of essential medications in rural health facilities [8][12] - The introduction of chronic disease certificates has significantly reduced medication costs for patients, demonstrating the effectiveness of policy in alleviating financial burdens [9][10] - Future reforms are expected to further expand coverage for chronic diseases and improve the efficiency of the reimbursement process, indicating a commitment to enhancing healthcare access for all [11][12]